ad

Renol Polychem IPO Listing at 0% Premium at ₹105 Per Share

Posted by : sachet | Thu Aug 07 2025

Renol Polychem IPO Listing at 0% Premium at ₹105 Per Share

Renol Polychem IPO listing: The Renol Polychem IPO was subscribed 6.83 times till its closing. In this subscription, 8.41 times were received by the qualified institutional buyers (QIBs) and 6.89 times by non-institutional investors (NIIs). The retail quota of the issue was subscribed to 53.59%. Before delving deeper into the topic, go through the details of the Renol Polychem IPO.

Renol Polychem IPO: It is a bookbuilding IPO of ₹25.77 crore, comprising a fresh issue of 24.54 lakh shares. The issue will be listed on NSE and SME on its tentative listing date, 7th August 2025. The Renol Polychem IPO date is fixed between 31st July 2025 and 4th August 2025. The face value of Renol Polychem IPO shares stands at ₹10 per share, and the IPO price band is set between ₹100 and ₹105 per share.

IPO Open Date31st July 2025
IPO Close Date4th August 2025
IPO Allotment Date5th August 2025
Refund Initiation 6th August 2025
Issue Size24,54,000 shares(aggregating up to ₹25.77 Cr)
Face Value₹10 per share
Lot Size1,200 Shares
Issue Price Band₹100 to ₹105 per share
Issue TypeBookbuilding IPO
Listing AtNSE & SME
Listing Date7th August 2025

Renol Polychem IPO Listing

On the NSE (National Stock Exchange), Renol Polychem is listed at ₹105 per share, reflecting a listing at a premium of 0% against the issue price of ₹105 per share.

About Renol Polychem IPO

Renol Polychem was incorporated in 2008, is engaged in the manufacturing and trading of specialising in colour masterbatches, plastic masterbatches, and industrial chemicals. The company caters to a wide range of customised polymer granules. The main focus of the company is to deliver high-quality products, customised solutions, and focus on sustainability through continuous improvement in innovation and customer-centric production.

  • Experienced management team
  • Focus on sustainability 
  • Business expansion plans
  • Competitive advantage
  • Technological advancement

Renol Polychem Limited Financials

The company’s financial analysis is essential before applying for the Renol Polychem IPO. Look at the table to learn about Renol Polychem Limited’s financials. 

Year Ended31st May 2025 (in cr.)31st March 2025 (in cr.)31st March 2024 (in cr.)31st March 2023 (in cr.)
Assets25.8623.4115.4910.28
Revenue12.0262.566.5241.86
Profit After Tax1.145.001.530.73
EBITDA1.607.072.181.14
Net Worth14.4713.338.692.71
Reserve and surplus8.987.843.20  –
Total Borrowing5.286.952.585.36

Explanation

 Renol Polychem Limited’s revenue soared by 859% from ₹6.52 crores in March 2024 to ₹62.56 crores in March 2025. Moreover, the company’s PAT increased by 226% from ₹1.53 crores to ₹5.00 crores.

Also Read : Adani Ports and Special Economic Zone Q1 Results FY26: Q1 PAT Rises 6.48% to ₹3,314.59 Crore; Revenue Up 20.72% YoY

Recent Articles

Best Penny Stocks for Long Term in India | Penny Stocks in 2025

Berger Paints Q1 Results FY26: Q1 PAT Narrows 11.01% to ₹314.63 Crore; Revenue Surged 3.55% YoY

Tega Industries Q1 Results FY26: Q1 PAT Falls 3.83% to ₹35.34 Crore; Revenue Jumps 4.74% YoY

Alembic Pharmaceuticals Q1 Results FY26: Q1 PAT Soars 14.60% to ₹154.38 Crore; Revenue Up 9.54% YoY

BLS International Services Q1 Results FY26: Q1 PAT Soars 49.76% to ₹171.00 Crore; Revenue Up 44.23% YoY